Ensitrelvir for the Treatment of Hospitalized Adults With COVID-19: An International Phase 3 Randomized Placebo-controlled Trial

Journal:

Clinical Infectious Diseases

Published:

2026-04-22

DOI:

10.1093/cid/ciag272

Affiliations:

58

Authors:

55

Go to article

Institutions	Authors	Share
University of Minnesota (UMN), United States of America (USA)	7.000000	0.13
University of Nebraska Medical Center (UNMC), United States of America (USA)	2.000000	0.04
Ivano-Frankivsk Central Clinical Hospital, Ukraine	2.000000	0.04
Infectious Diseases, AIDS and Clinical Immunology Research Center, Georgia	2.000000	0.04
University of Colorado Anschutz Medical Campus (CU Anschutz), United States of America (USA)	2.000000	0.04
Germans Trias i Pujol University Hospital (HUGTP), ICS, Spain	2.000000	0.04
The University of Texas Southwestern Medical Center (UT Southwestern Medical Center), United States of America (USA)	2.000000	0.04
Vanderbilt University Medical Center (VUMC), United States of America (USA)	2.000000	0.04
Shionogi, Japan	2.000000	0.04
NIH National Institute of Allergy and Infectious Diseases (NIAID), United States of America (USA)	2.000000	0.04
UCL, United Kingdom (UK)	1.333333	0.02
National and Kapodistrian University of Athens (UOA), Greece	1.000000	0.02
Duke University Health System, United States of America (USA)	1.000000	0.02
Wake Forest University (WFU), United States of America (USA)	1.000000	0.02
National Institute of Global Health and Medicine, Japan	1.000000	0.02
Faculty of Medicine Siriraj Hospital, MU, Thailand	1.000000	0.02
Khon Kaen University, Thailand	1.000000	0.02
Fujita Health University, Japan	1.000000	0.02
ADONIS Medical Group, Ukraine	1.000000	0.02
The Catholic University of Korea (CUK), South Korea	1.000000	0.02
University of Kansas Medical Center (KUMC), United States of America (USA)	1.000000	0.02
University of Cincinnati (UC), United States of America (USA)	1.000000	0.02
University of California, San Francisco (UCSF), United States of America (USA)	1.000000	0.02
NewYork-Presbyterian / Weill Cornell Medical Center, United States of America (USA)	1.000000	0.02
University of Illinois at Chicago (UIC), United States of America (USA)	1.000000	0.02
NYU Langone Health, United States of America (USA)	1.000000	0.02
Michael E. DeBakey VA Medical Center (MEDVAMC), United States of America (USA)	1.000000	0.02
Shionogi - USA, United States of America (USA)	1.000000	0.02
Icahn School of Medicine at Mount Sinai (ISMMS), MSHS, United States of America (USA)	1.000000	0.02
Washington DC VA Medical Center, United States of America (USA)	1.000000	0.02
Frederick National Laboratory for Cancer Research (FNLCR), United States of America (USA)	1.000000	0.02
University of New South Wales (UNSW Sydney), Australia	1.000000	0.02
Coordinación en Investigación Clínica Académica en Latinoamérica (CICAL), Argentina	0.500000	0.01
Hospital General de Agudos José María Ramos Mejia, Argentina	0.500000	0.01
Virginia Polytechnic Institute and State University (Virginia Tech), United States of America (USA)	0.500000	0.01
Salem VA Medical Center, United States of America (USA)	0.500000	0.01
Thai Red Cross Society, Thailand	0.500000	0.01
Chulalongkorn University (CU), Thailand	0.500000	0.01
Intermountain Healthcare, United States of America (USA)	0.500000	0.01
Health Sciences Center (HSC), Utah, United States of America (USA)	0.500000	0.01
UC Davis Health, United States of America (USA)	0.500000	0.01
VA Northern California Health Care System, United States of America (USA)	0.500000	0.01
VA Portland Health Care System (VAPORHCS), United States of America (USA)	0.500000	0.01
Oregon Health and Science University (OHSU), United States of America (USA)	0.500000	0.01
Copenhagen University Hospital (CUH), Denmark	0.500000	0.01
University of Copenhagen (UCPH), Denmark	0.500000	0.01
Guy's and St Thomas' NHS Foundation Trust, United Kingdom (UK)	0.333333	0.01
King's College London (KCL), United Kingdom (UK)	0.333333	0.01

Interested in Medical Microbiology?